A phase II trial of uracil ointment for the prevention of capecitabine induced hand-foot syndrome (HFS): .
Not Applicable
- Conditions
- Advanced or recurrent breast cancer
- Registration Number
- JPRN-UMIN000013098
- Lead Sponsor
- Kyoto Prefectural University of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
Had previous treatment with capecitabine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method